Sydney - Thursday - October 13: (RWE Aust Business News) -
Pharmanet Group Ltd's (ASX:PNO) subsidiary Molecular Pharmacology Ltd (MPL) has entered into a distribution and supply agreement with Molecular Pharmacology (USA) Ltd (MPL USA).
MPL USA is granted the exclusive right to distribute, market, promote and/or sell topical therapeutic products for analgesic and anti-inflammatory use in humans in the USA.
It will be able to utilise the MPL trademarks and tradenames associated with the licenced product.
MPL currently holds the licensing rights from Cambridge Scientific Pty Ltd, a wholly owned subsidiary of the company and the holder of the intellectual property.
- Forums
- ASX - By Stock
- CAI
- pharmanet in distribution agreement with mpl usa
pharmanet in distribution agreement with mpl usa
Featured News
Add CAI (ASX) to my watchlist
|
|||||
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.53M |
Open | High | Low | Value | Volume |
11.0¢ | 11.0¢ | 10.5¢ | $42.03K | 398.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
27 | 1631596 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 463235 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 1554396 | 0.105 |
30 | 2046200 | 0.100 |
3 | 64000 | 0.096 |
3 | 625000 | 0.095 |
1 | 100000 | 0.094 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 378548 | 9 |
0.115 | 537941 | 4 |
0.120 | 570987 | 10 |
0.125 | 627823 | 8 |
0.130 | 618243 | 9 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
CAI (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online